Recent studies reported a microglia-mediated neuroprotective effect following GPR55 activation both in an in vitro model of rat hippocampal slice cultures [20] and in a mouse model of Parkinson’s disease (PD) [21], corroborated by subsequent evidence that GPR55 agonists attenuate injury in neural stem cells [22]. Here, GPR55 is linked to Parkinson disease.